Zoledronic Acid Market Size in 2022, Share, Opportunities, Top Manufacturers, Revenue, Trends, Forecast 2028

Zoledronic acid, also known as zoledronate, is a medication used to treat a number of bone diseases. These include osteoporosis, high blood calcium due to cancer, bone breakdown due to cancer, and Paget’s disease of bone. It is given by injection into a vein.Report OverviewDue to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at USD million in the year 2022, is projected to reach a revised size of USD million by 2028, growing at a CAGR of percent during the forecast period 2022-2028.The USA market for Zoledronic Acid is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of percent during the forecast period of 2023 through 2028.The China market for Zoledronic Acid is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of percent during the forecast period of 2023 through 2028.The Europe market for Zoledronic Acid is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of percent during the forecast period of 2023 through 2028.The global key manufacturers of Zoledronic Acid include Mylan, Eli Lilly, Pfizer, Apotex, Teva, Amgen, Tecoland, Novartis and Emcure Pharma, etc. In 2021, the global top five players had a share approximately percent in terms of revenue.